Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 35  Show
  1. 1
    "Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT)."
    Lu R., Kanai N., Bao Y., Schuster V.L.
    J. Clin. Invest. 98:1142-1149(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], VARIANT THR-396.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Molecular cloning of the gene for the human prostaglandin transporter hPGT: gene organization, promoter activity, and chromosomal localization."
    Lu R., Schuster V.L.
    Biochem. Biophys. Res. Commun. 246:805-812(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-396.
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Brain and Prostate.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50494 other entries.

  5. 5
    "Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing."
    Seifert W., Kuhnisch J., Tuysuz B., Specker C., Brouwers A., Horn D.
    Hum. Mutat. 33:660-664(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: TISSUE SPECIFICITY, VARIANT PHOAR2 SER-557.
    Category: Pathology & Biotech, Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  6. 6
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 5326 and mapped to 3 other entries.

  7. 7
    "Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy."
    Zhang Z., Xia W., He J., Zhang Z., Ke Y., Yue H., Wang C., Zhang H., Gu J., Hu W., Fu W., Hu Y., Li M., Liu Y.
    Am. J. Hum. Genet. 90:125-132(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS PHOAR2 ARG-222 AND GLU-255.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  8. 8
    Cited for: VARIANTS PHOAR2 PHE-85; HIS-97; ALA-181; ASP-181; LEU-204; ARG-222; PHE-420 AND GLY-565, VARIANT CYS-445, CHARACTERIZATION OF VARIANT PHOAR2 PHE-420.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  9. 9
    "Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing."
    Busch J., Frank V., Bachmann N., Otsuka A., Oji V., Metze D., Shah K., Danda S., Watzer B., Traupe H., Bolz H.J., Kabashima K., Bergmann C.
    J. Invest. Dermatol. 132:2473-2476(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS PHOAR2 ARG-255 AND HIS-556.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  10. 10
    "Genetic factors related to unconjugated hyperbilirubinemia amongst adults."
    Huang C.S., Huang M.J., Lin M.S., Yang S.S., Teng H.C., Tang K.S.
    Pharmacogenet. Genomics 15:43-50(2005) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-disease association. (HuGE Navigator)Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 50 other entries.

  11. 11
    "Functional characterization of prostaglandin transporter and terminal prostaglandin synthases during decidualization of human endometrial stromal cells."
    Kang J., Chapdelaine P., Laberge P.Y., Fortier M.A.
    Hum. Reprod. 21:592-599(2006) [PubMed] [Europe PMC] [Abstract]
    Annotation: Human endometrial stromal cells treated with a combination of cAMP and medroxyprogesterone acetate to induce decidualization showed an increase in protein and mRNA levels.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  12. 12
    "Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening."
    Wu C., Ma M.H., Brown K.R., Geisler M., Li L., Tzeng E., Jia C.Y., Jurisica I., Li S.S.
    Proteomics 7:1775-1785(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q92959.

    This publication is mapped to 330 other entries.

  13. 13
    "Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls."
    Choi K., Zhuang H., Crain B., Dore S.
    J. Neuroimmunol. 195:81-87(2008) [PubMed] [Europe PMC] [Abstract]
    Annotation: PGT level was significantly less in AD than in age-matched control brain homogenates.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  14. 14
    "Regulation of prostaglandin transporters in colorectal neoplasia."
    Holla V.R., Backlund M.G., Yang P., Newman R.A., DuBois R.N.
    Cancer Prev Res (Phila) 1:93-99(2008) [PubMed] [Europe PMC] [Abstract]
    Annotation: The existing model to explain increased PGE(2) in colorectal neoplasia should be modified to include the novel mechanism of coordinated up- and down-regulation of genes involved in PGE(2) transport.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 10 other entries.

  15. 15
    "The prostaglandin transporter PGT transports PGH(2)."
    Chi Y., Schuster V.L.
    Biochem. Biophys. Res. Commun. 395:168-172(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: that PGT may play a role in transporting PGH(2) across cellular membranes.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  16. 16
    "Differential expression of the enzymatic system controlling synthesis, metabolism, and transport of PGF2 alpha in human fetal membranes."
    Breuiller-Fouche M., Leroy M.J., Dubois O., Reinaud P., Chissey A., Qi H., Germain G., Fortier M.A., Charpigny G.
    Biol. Reprod. 83:155-162(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: expression in fetal membranesfound primarily in the choriodeciduaImported.
    Source: GeneRIF:6578.

    This publication is mapped to 7 other entries.

  17. 17
    "L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms."
    Yokoyama K., Urashima M., Ohkido I., Kono T., Yoshida T., Muramatsu M., Niu T., Hosoya T.
    Nephron Clin Pract 115:c237-43(2010) [PubMed] [Europe PMC] [Abstract]
    Annotation: Observational study of gene-disease association. (HuGE Navigator)Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 682 other entries.

  18. 18
    "Lack of association between polymorphisms in the prostaglandin F2alpha receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs."
    McCarty C.A., Berg R., Patchett R., Wilke R.A., Burmester J.K.
    Ophthalmic Genet. 33:74-76(2012) [PubMed] [Europe PMC] [Abstract]
    Annotation: we found no indication for an association between SNPs in the prostaglandin F(2alpha) receptor gene or SLCO2A1 and IOP response to prostaglandin analogs in a population of European descent.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 6 other entries.

  19. 19
    "Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis."
    Sasaki T., Niizeki H., Shimizu A., Shiohama A., Hirakiyama A., Okuyama T., Seki A., Kabashima K., Otsuka A., Ishiko A., Tanese K., Miyakawa S., Sakabe J., Kuwahara M., Amagai M., Okano H., Suematsu M., Kudoh J.
    J. Dermatol. Sci. 68:36-44(2012) [PubMed] [Europe PMC] [Abstract]
    Annotation: Report SLCO2A1 is a novel gene responsible for pachydermoperiostosis in Japanese patients.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  20. 20
    "Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization."
    Zhang Z., He J.W., Fu W.Z., Zhang C.Q., Zhang Z.L.
    J. Clin. Endocrinol. Metab. 98:E923-33(2013) [PubMed] [Europe PMC] [Abstract]
    Annotation: genetic association study in population in China: Nine different SLCO2A1 mutations were identified in subjects with primary hypertrophic osteoarthropathy (PHO) in 7 previously undescribed families; different homozygous mutations of SLCO2A1 cause PHO.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  21. 21
    "Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy."
    Cheng R., Li M., Guo Y., Yao Y., Gao C., Yao Z.
    Eur J Dermatol 23:636-639(2013) [PubMed] [Europe PMC] [Abstract]
    Annotation: Three novel mutations within the SLCO2A1 gene have been demonstrated to be associated with Chinese primary hypertrophic osteoarthropathy patients.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  22. 22
    "Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy."
    Zhang Z., He J.W., Fu W.Z., Zhang C.Q., Zhang Z.L.
    Gene 534:421-423(2014) [PubMed] [Europe PMC] [Abstract]
    Annotation: Identified two novel mutations in SLCO2A1.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  23. 23
    "Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development."
    Pereira C., Queiros S., Galaghar A., Sousa H., Pimentel-Nunes P., Brandao C., Moreira-Dias L., Medeiros R., Dinis-Ribeiro M.
    PLoS ONE 9:e92000-e92000(2014) [PubMed] [Europe PMC] [Abstract]
    Annotation: Genetic variability in key genes in prostaglandin E2 pathway (COX-2 HPGD ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.Imported.
    Source: GeneRIF:6578.

    This publication is mapped to 18 other entries.

  24. 24
    "Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance."
    Guda K., Fink S.P., Milne G.L., Molyneaux N., Ravi L., Lewis S.M., Dannenberg A.J., Montgomery C.G., Zhang S., Willis J., Wiesner G.L., Markowitz S.D.
    Cancer Prev Res (Phila) 7:805-812(2014) [PubMed] [Europe PMC] [Abstract]
    Annotation: SLCO2A1 has a role in familial digital clubbing colon neoplasia and NSAID resistanceImported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

  25. 25
    "The complete type of pachydermoperiostosis: a novel nonsense mutation p.E141* of the SLCO2A1 gene."
    Niizeki H., Shiohama A., Sasaki T., Seki A., Kabashima K., Otsuka A., Kosaki K., Ogo A., Yamada T., Miyasaka M., Matsuoka K., Hirakiyama A., Okuyama T., Matsuda M., Nakabayashi K., Tanese K., Ishiko A., Amagai M., Kudoh J.
    J. Dermatol. Sci. 75:193-195(2014) [PubMed] [Europe PMC] [Abstract]
    Annotation: a novel nonsense mutation p.E141* of the SLCO2A1 gene is associated with pachydermoperiostosisImported.
    Source: GeneRIF:6578.

    This publication is mapped to 3 other entries.

1 to 25 of 35  Show